» Articles » PMID: 22147108

Identification of Forty Cases with Alkaptonuria in One Village in Jordan

Overview
Journal Rheumatol Int
Specialty Rheumatology
Date 2011 Dec 8
PMID 22147108
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Alkaptonuria (AKU) is one of the four initially identified inborn errors of metabolism. The prevalence of AKU is unknown in Jordan. Therefore, a research project was started in April 2009 at the Faculty of Medicine/Mutah University in southern Jordan. The aims of the project were to identify people with AKU, to screen all family members with history of AKU, and to increase the awareness about the disease among health care professionals and the community in southern Jordan. Targeted family screening method was used to identify patients with AKU. In this paper, we present preliminary results of screening 17 families with history of AKU in a single village in southern region of Jordan. Forty cases with AKU were identified in this village (age range, 1-60 years). Early cases with AKU were diagnosed through out this study, two-third of patients (n = 28) were under the age of thirty. Interestingly, nine cases with AKU were identified in one family. Our experience suggests that for the identification of cases with AKU where consanguinity is common, the focus for screening should be extended to all family members. The prevalence of AKU among Jordanian is likely to be greater than the prevalence rates worldwide due to high rates of consanguineous marriages. Further studies and effective screening programs are needed to detect undiagnosed cases of AKU, to provide genetic counseling, and ultimately to prevent the occurrence of new cases of AKU in Jordan.

Citing Articles

Alkaptonuria.

Bernardini G, Braconi D, Zatkova A, Sireau N, Kujawa M, Introne W Nat Rev Dis Primers. 2024; 10(1):16.

PMID: 38453957 DOI: 10.1038/s41572-024-00498-x.


Reverse Total Shoulder Arthroplasty in Alkaptonuric Shoulder: Case Presentation, Review of Literature, and Technical Considerations.

Dawod M, Alswerki M, Darabah A, Satari A, Alrwashdeh A, Alaqarbeh Z Orthop Res Rev. 2023; 15:69-77.

PMID: 37091223 PMC: 10115201. DOI: 10.2147/ORR.S402214.


Development of an Effective Therapy for Alkaptonuria - Lessons for Osteoarthritis.

Gallagher J, Dillon J, Ranganath L Rheumatol Immunol Res. 2022; 2(2):79-85.

PMID: 36465977 PMC: 9524786. DOI: 10.2478/rir-2021-0011.


A robust bacterial high-throughput screening system to evaluate single nucleotide polymorphisms of human homogentisate 1,2-dioxygenase in the context of alkaptonuria.

Lequeue S, Neuckermans J, Nulmans I, Schwaneberg U, Vanhaecke T, Kock J Sci Rep. 2022; 12(1):19452.

PMID: 36376482 PMC: 9663557. DOI: 10.1038/s41598-022-23702-y.


Urological Aspects in Patients with Alkaptonuria: A Case-Control Study.

Suoub M, Alsbou M, Sawaqed F Am J Mens Health. 2020; 14(5):1557988320969310.

PMID: 33118482 PMC: 7607800. DOI: 10.1177/1557988320969310.


References
1.
La Du B, Zannoni V, LASTER L, Seegmiller J . The nature of the defect in tyrosine metabolism in alcaptonuria. J Biol Chem. 1958; 230(1):251-60. View

2.
Stenn F, Milgram J, Lee S, Weigand R, Veis A . Biochemical identification of homogentisic acid pigment in an ochronotic egyptian mummy. Science. 1977; 197(4303):566-8. DOI: 10.1126/science.327549. View

3.
Wolff J, Barshop B, Nyhan W, Leslie J, Seegmiller J, Gruber H . Effects of ascorbic acid in alkaptonuria: alterations in benzoquinone acetic acid and an ontogenic effect in infancy. Pediatr Res. 1989; 26(2):140-4. DOI: 10.1203/00006450-198908000-00015. View

4.
Mayatepek E, Kallas K, Anninos A, Muller E . Effects of ascorbic acid and low-protein diet in alkaptonuria. Eur J Pediatr. 1998; 157(10):867-8. DOI: 10.1007/s004310050956. View

5.
Zatkova A, de Bernabe D, Polakova H, Zvarik M, Ferakova E, Bosak V . High frequency of alkaptonuria in Slovakia: evidence for the appearance of multiple mutations in HGO involving different mutational hot spots. Am J Hum Genet. 2000; 67(5):1333-9. PMC: 1288576. DOI: 10.1016/S0002-9297(07)62964-4. View